Clinical Trials
579 trialsOUTREACH
Mina Alpha Limited
The Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Hepatocellular Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan
RAISE
Sun Yat-sen University
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital
HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC
Hunan Provincial People's Hospital
HELIO
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
Eutilex
OPTIMAL
Rigshospitalet, Denmark
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma
Fudan University
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Suzhou Kintor Pharmaceutical Inc,
HAI-TL
Eastern Hepatobiliary Surgery Hospital
A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma
Huashan Hospital
Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC
Peking Union Medical College Hospital
HCC
Sinocelltech Ltd.
Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC
Guangxi Medical University
Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC
Guangxi Medical University
PREVENT-2
Guangxi Medical University
FAPI
Guangdong Provincial People's Hospital
Longitudinal Immune-phenotyping of HCC Following MK-3475
National Cancer Centre, Singapore
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
Beijing YouAn Hospital
SBRT With DIBH for HCC After TACE and Lipiodol Marking
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Notable-HCC
Shandong Cancer Hospital and Institute
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Shanghai Ming Ju Biotechnology Co., Ltd.
A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy
National Atomic Research Institute, Taiwan
A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy
Southwest Hospital, China
CCGLC-003
Tongji Hospital
CCGLC-004
Tongji Hospital
CCGLC-007
Tongji Hospital
TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma
Zhongda Hospital
PETMRIinHCC
University Health Network, Toronto
Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.
Hospital Sirio-Libanes
EMERITUS-2
Radboud University Medical Center
SARCOLIVER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC
First Affiliated Hospital of Fujian Medical University
NWRD06 DNA Plasmid for HCC After Radical Resection
Newish Technology (Beijing) Co., Ltd.
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
Clinica Universidad de Navarra, Universidad de Navarra
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
Third Affiliated Hospital, Sun Yat-Sen University
CAT_PB
Lebanese University
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Newish Technology (Beijing) Co., Ltd.
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.
Institute of Liver and Biliary Sciences, India
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
First Affiliated Hospital of Guangxi Medical University
Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC
Second Affiliated Hospital of Guangzhou Medical University
OASES
Gongwin Biopharm Co., Ltd.
FAITH
Shanghai Zhongshan Hospital
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.
China Three Gorges University, Yichang, China